IL6 and neoplasm: At Day 13 p.i., CHXscr mice exhibited reduced tumour‐free body weight (−22%) (Figure 7B), a prominent reduction in adipose tissue‐ and skeletal muscle weights, marked splenomegaly (Figures 7C), and high plasma IL‐6 concentrations (Figure 7D).